Oncology

Chronic Graft-versus-Host Disease

Advertisment

Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in cGVHD Treatment

expert perspectives by Corey Cutler, MD, MPH, FRCPC; Daniel R. Couriel, MD, MS; Sergio A. Giralt, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Chronic Graft-versus-Host Disease will feature selected topics in cGVHD that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Daniel R. Couriel, MD, MS

Professor of Internal Medicine
HCI Chair for Adult Leukemia Research
Director, Utah Blood and Marrow Transplant Program
Medical Director, Center for Cellular Therapy and Regenerative Medicine
Division of Hematology and Hematologic Malignancies
Huntsman Cancer Institute
University of Utah School of Medicine
Salt Lake City, UT

Corey Cutler,, MD, MPH, FRCPC

Medical Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Sergio A. Giralt, MD

Deputy Division Head
Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY

Community-Selected Topics: 

Expert Roundtables 

    Optimizing the Chronic Graft-versus-Host Disease Treatment Paradigm
    Chronic Graft-versus-Host Disease: Current Challenges and Opportunities
    Refractory Chronic Graft-versus-Host Disease: Management and Monitoring Recommendations
    Preventing and Treating Chronic Graft-versus-Host Disease Without Compromising Antitumor Effects

Clinical Topic Updates 

    Refractory Chronic Graft-versus-Host Disease: Choosing Immunosuppressive/Immunomodulating Agents
    Screening for Chronic Graft-versus-Host Disease–Associated Comorbidities
    Updates on Preventive Measures for Chronic Graft-versus-Host Disease
    Targeting Cytokine Pathways in Chronic Graft-versus-Host Disease: Drivers of Fibrosis and Inflammation

Patient Care Perspectives

    Tailoring Care to Organ-Specific Manifestations of Chronic Graft-versus-Host Disease
    Principles of Multispecialty Care for Refractory Chronic Graft-versus-Host Disease
    Patients With Ongoing Chronic Graft-versus-Host Disease: Tracking and Adjusting Treatment
    Role of Adjunctive Nonsystemic Therapies in Chronic Graft-versus-Host Disease

Corey Cutler, MD, MPH, FRCPC

Medical Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Daniel R. Couriel, MD, MS

Professor of Internal Medicine
HCI Chair for Adult Leukemia Research
Director, Utah Blood and Marrow Transplant Program
Medical Director, Center for Cellular Therapy and Regenerative Medicine
Division of Hematology and Hematologic Malignancies
Huntsman Cancer Institute
University of Utah School of Medicine
Salt Lake City, UT

Sergio A. Giralt, MD

Deputy Division Head
Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY

Advertisment